GeneDx Holdings Corp.
Diagnostics & Research
Healthcare
WGS
28.15 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
129.64
52 week high
132.54
high
131.40
52 week low
0.00
low
120.89
growth
200.67 %
previous Close
129.79
P/E ratio
market cap
2.61 B
div yield
0
net incoming
-6.53 M
-220.06 %
net profit margin
-7.49 %
-13.00 %
operating incoming
-4.55 M
-151.68 %
net change in cash
14.49 M
-46.96 %
cash on hand
99.70 M
17.01 %
cost of revenue
28.64 M
-2.70 %
top